| Ticker Details |
|
Elanco Animal Health Incorporated
|
| IPO Date: |
September 17, 2018 |
| Sector: |
Healthcare |
| Industry: |
Drug Manufacturers - Specialty and Generic |
| Market Cap: |
$12.41B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.34 | 1.61%
|
| Avg Daily Range (30 D): |
$0.35 | 1.43%
|
| Avg Daily Range (90 D): |
$0.35 | 1.52%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
4.36M |
| Avg Daily Volume (30 D): |
3.76M |
| Avg Daily Volume (90 D): |
4.11M |
| Trade Size |
| Avg Trade Size (Sh.): |
147 |
| Avg Trade Size (Sh.) (30 D): |
92 |
| Avg Trade Size (Sh.) (90 D): |
97 |
| Institutional Trades |
| Total Institutional Trades: |
15,246 |
| Avg Institutional Trade: |
$3.56M |
| Avg Institutional Trade (30 D): |
$4.03M |
| Avg Institutional Trade (90 D): |
$4.27M |
| Avg Institutional Trade Volume: |
.16M |
| Avg Institutional Trades (Per Day): |
8 |
| Market Closing Trades |
| Avg Closing Trade: |
$12.94M |
| Avg Closing Trade (30 D): |
$20.56M |
| Avg Closing Trade (90 D): |
$18.81M |
| Avg Closing Volume: |
628.67K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$.07
|
$-.07
|
$.02
|
|
Diluted EPS
|
$.07
|
$-.07
|
$.02
|
|
Revenue
|
$4.59B
|
$1.14B
|
$1.24B
|
|
Gross Profit
|
$2.52B
|
$607M
|
$713M
|
|
Net Income / Loss
|
$36M
|
$-34M
|
$11M
|
|
Operating Income / Loss
|
$-16M
|
$-50M
|
$25M
|
|
Cost of Revenue
|
$2.07B
|
$530M
|
$528M
|
|
Net Cash Flow
|
$15M
|
$-34M
|
$52M
|
|
PE Ratio
|
381.51
|
|
|
|
|
|